Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Solexa and collaborating scientists illuminate the small RNA component of the transcriptome

07.09.2005


Research published in Science demonstrates the value of high-throughput sequencing in small RNA analysis

Solexa, Inc. (Nasdaq: SLXA) today announced that its researchers in collaboration with the Delaware Biotechnology Institute and the University of Delaware reported the most comprehensive analysis to date of the small RNA component of the transcriptome. The research, "Elucidation of the Small RNA Component of the Transcriptome," was published in the September 2, 2005 issue of the peer-reviewed journal Science. Solexa’s assay can be used to elucidate small RNAs in any plant or animal species, notably humans.
"Finding that small RNAs comprise a potent set of regulatory molecules in diverse organisms is among the most important discoveries in the past 10 years," stated John West, Solexa’s chief executive officer. "This research is pioneering in its ability to characterize these important regulatory molecules on a genome-wide scale."


Solexa’s technology has the advantage of producing highly accurate, reproducible and quantitative readouts of the full complement of activated genes and small RNAs, including genes expressed at low levels, without requiring advance knowledge of the genes or sequences of interest. Solexa performed this research in its Genomic Services business unit. The Company also intends to develop this small RNA assay for use with its next-generation sequencing platform, which is scheduled to be introduced to the market by the end of this year.

Using Solexa’s unique high-throughput sequencing technology, the study identified over 77,000 unique small RNAs in Arabidopsis plants, 10 times more than previously known. This study, funded by the National Science Foundation, generated more than two million short DNA sequences, known as signature sequences or sequence tags, to identify and quantify both known and novel small RNA molecules. Many regions of the Arabidopsis genome previously considered to be inactive or featureless were found to be sites of considerable small RNA activity.

"The signature sequencing approach makes possible the study of global identity, regulation and function of small RNA populations in diverse organisms. This extensive small RNA data will help biologists understand small RNAs and their regulation," said Blake Meyers, an Assistant Professor at the University of Delaware and a senior author on the study. "We have also released an enhanced version of our Arabidopsis MPSS website (http://mpss.udel.edu/at) to further facilitate public access and use of these data."

"These experiments underscore the importance of studying the entire genome for evidence of small RNA activity. The newly discovered small RNAs that match to genes are exciting, but so are those that derive from relatively featureless regions between genes," added Pamela J. Green, a professor at the University of Delaware and the Delaware Biotechnology Institute, another senior author on the study.

About small RNAs

The two major categories of small RNAs are microRNAs (miRNAs) and small interfering RNAs (siRNAs). Small RNAs function to silence genes by inhibiting the synthesis or function of mRNA. Deficiencies in small RNA production can have a profound effect on development, and small RNAs have been associated with other important biological processes such as stress responses. In addition, recent data suggests a possible role for small RNA profiling in cancer diagnostics.

About Solexa

Solexa, Inc. is developing and preparing to commercialize a new genetic analysis instrument system which will be used to perform a range of analyses including whole genome resequencing, gene expression analysis and small RNA analysis. We expect the first generation of Solexa’s new technology to generate over a billion bases of DNA sequence per run and to enable whole genome resequencing below $100,000 per sample, making it the first platform to reach this important milestone. Solexa’s longer-term goal is to reduce the cost of human re-sequencing to a few thousand dollars for use in a wide range of applications from basic research through clinical diagnostics. The Company expects to introduce its first instrument system by the end of 2005.

This press release contains "forward-looking" statements, including statements related to the current views of Solexa management as to future products, product development including the commercial introduction of the Company’s novel genetic analysis technology, the expansion and success of Solexa’s commercial application of its genomics technologies and the future financial performance of Solexa. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "predicts," "expects," "envisions," "hopes," "estimates," "intends," "will," "continue," "may," "potential," "should," "confident," "could" and similar expressions are intended to identify forward-looking statements. There can be no assurance that such expectations of any of the forward-looking statements will prove to be correct, and actual results could differ materially from those projected or assumed in the forward-looking statements. There are a number of important factors that could cause the results of Solexa to differ materially from those indicated by these forward-looking statements including, among others, risks detailed from time to time in the Company’s SEC reports, including its Annual Report on Form 10-K for the year ended December 31, 2004 and its Form 10-Q for the quarter ended June 30, 2005. Solexa does not undertake any obligation to update forward-looking statements.

Contacts:

Solexa, Inc.
Omead Ostadan
Vice President of Marketing
(510) 670-9300 Omead.Ostadan@solexa.com

European Media Contact:
Northbank Communications
Sue Charles, CEO
+44 (0)20 7886 8152 s.charles@northbankcommunications.com

Lippert/Heilshorn & Associates
Investor Contacts:
Jody Cain (jcain@lhai.com)
Bruce Voss (bvoss@lhai.com)

U.S. Media Contact:
Mark Stuart (mstuart@lhai.com) (310) 691-7100

Mark Stuart | EurekAlert!
Further information:
http://www.lhai.com
http://www.solexa.com

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

DGIST develops 20 times faster biosensor

24.04.2017 | Physics and Astronomy

Nanoimprinted hyperlens array: Paving the way for practical super-resolution imaging

24.04.2017 | Materials Sciences

Atomic-level motion may drive bacteria's ability to evade immune system defenses

24.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>